Received Nov 3, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (MODERNA)) | MODERNA | 2 | — | — |
Covid; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Covid) in an elderly female patient who received mRNA-1273 (Spikevax) for COVID-19 prophylaxis. No Medical History information was reported. In February 2022, the patient received second dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, the patient experienced COVID-19 (Covid). At the time of the report, COVID-19 (Covid) outcome was unknown. No concomitant medications were provided. The patient had COVID after 2nd dose of the Moderna COVID-19 vaccine in February 2022. No treatment medication was provided. This case was linked to MOD-2025-790630 (Patient Link).